Johnson & Johnson (JNJ)

Basic

  • Market Cap

    $381.26B

  • EV

    $387.67B

  • Shares Out

    2,407.28M

  • Revenue

    $98.66B

  • Employees

    152,700

Margins

  • Gross

    67.56%

  • EBITDA

    35.49%

  • Operating

    27.97%

  • Pre-Tax

    16.67%

  • Net

    35.1%

  • FCF

    15.95%

Returns (5Yr Avg)

  • ROA

    8.44%

  • ROE

    25.81%

  • ROCE

    17.67%

  • ROIC

    16.12%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $174.55

  • P/E

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

Per Share

  • Rev

    $38.16

  • Earnings (Dil)

    $13.23

  • FCF

    $6.02

  • Book Value

    $29.59

Growth (CAGR)

  • Rev 3Yr

    6.86%

  • Rev 5Yr

    3.92%

  • Rev 10Yr

    3.42%

  • Dil EPS 3Yr

    -5.67%

  • Dil EPS 5Yr

    56.48%

  • Dil EPS 10Yr

    1.76%

  • Rev Fwd 2Yr

    -3.89%

  • EBITDA Fwd 2Yr

    1.36%

  • EPS Fwd 2Yr

    3.18%

  • EPS LT Growth Est

    2.9%

Dividends

  • Yield

  • Payout

    85.73%

  • DPS

    $4.64

  • DPS Growth 3Yr

    5.78%

  • DPS Growth 5Yr

    5.92%

  • DPS Growth 10Yr

    6.21%

  • DPS Growth Fwd 2Yr

    4.85%

Select a metric from the list below to chart it

Dec '13
Jan '16
Dec '17
Dec '19
Jan '22
LTM

Total Revenues

81,581.0

82,059.0

82,584.0

93,775.0

94,943.0

98,656.0

Total Revenues % Chg.

6.7%

0.6%

0.6%

13.6%

1.2%

16.3%

Cost of Goods Sold, Total

27,091.0

27,556.0

28,427.0

29,855.0

30,989.0

32,006.0

Gross Profit

54,490.0

54,503.0

54,157.0

63,920.0

63,954.0

66,650.0

Selling General & Admin Expenses, Total

22,540.0

21,885.0

21,731.0

24,055.0

23,604.0

24,268.0

R&D Expenses

10,775.0

11,355.0

12,159.0

14,714.0

14,603.0

14,783.0

Other Operating Expenses, Total

33,315.0

33,240.0

33,890.0

38,769.0

38,207.0

39,051.0

Operating Income

21,175.0

21,263.0

20,267.0

25,151.0

25,747.0

27,599.0

Interest Expense, Total

-1,005.0

-318.0

-201.0

-183.0

-276.0

-798.0

Interest And Investment Income

611.0

357.0

111.0

53.0

490.0

1,152.0

Net Interest Expenses

-394.0

39.0

-90.0

-130.0

214.0

354.0

Currency Exchange Gains (Loss)

-265.0

-267.0

-209.0

-236.0

-328.0

-493.0

Other Non Operating Income (Expenses)

-1,099.0

-3,909.0

-2,922.0

1,632.0

1,832.0

2,947.0

EBT, Excl. Unusual Items

19,417.0

17,126.0

17,046.0

26,417.0

27,465.0

30,407.0

Restructuring Charges

-251.0

-266.0

-247.0

-352.0

-521.0

-980.0

Merger & Related Restructuring Charges

-117.0

-300.0

-400.0

Gain (Loss) On Sale Of Investments

300.0

1.0

500.0

-700.0

-1,937.0

Gain (Loss) On Sale Of Assets

1,217.0

2,154.0

111.0

617.0

380.0

284.0

Asset Writedown

-1,258.0

-1,096.0

-233.0

-989.0

-1,216.0

-1,604.0

In Process R&D Expenses

-1,126.0

-890.0

-181.0

-900.0

-783.0

-428.0

Legal Settlements

-2,300.0

-900.0

-7,000.0

Other Unusual Items

-100.0

-1,700.0

-1,900.0

EBT, Incl. Unusual Items

17,999.0

17,328.0

16,497.0

22,776.0

21,725.0

16,442.0

Income Tax Expense

2,702.0

2,209.0

1,783.0

1,898.0

3,784.0

2,450.0

Earnings From Continuing Operations

15,297.0

15,119.0

14,714.0

20,878.0

17,941.0

13,992.0

Earnings Of Discontinued Operations

20,632.0

Net Income

15,297.0

15,119.0

14,714.0

20,878.0

17,941.0

34,624.0

Net Income to Common Incl Extra Items

15,297.0

15,119.0

14,714.0

20,878.0

17,941.0

34,624.0

Net Income to Common Excl. Extra Items

15,297.0

15,119.0

14,714.0

20,878.0

17,941.0

13,992.0

Total Shares Outstanding

2,662.3

2,632.5

2,632.5

2,629.0

2,613.6

2,407.2

Weighted Avg. Shares Outstanding

2,681.5

2,645.1

2,632.8

2,632.1

2,625.2

2,585.2

Weighted Avg. Shares Outstanding Dil

2,728.7

2,684.3

2,670.7

2,674.0

2,663.9

2,615.8

EPS

5.7

5.7

5.6

7.9

6.8

13.4

EPS Diluted

5.6

5.6

5.5

7.8

6.7

13.2

EBITDA

28,104.0

28,272.0

27,498.0

32,541.0

32,717.0

35,014.0